Cholestech to Present at the Sidoti & Company Emerging Growth Institutional Investor Conference
23 März 2007 - 12:52AM
PR Newswire (US)
HAYWARD, Calif., March 22 /PRNewswire-FirstCall/ -- Cholestech
Corporation (NASDAQ:CTEC), a leading manufacturer of point of care
testing devices, today announced that Ken Miller, Vice President of
Sales and Marketing will present at the Sidoti & Company
Emerging Growth Institutional Investor Conference on Tuesday, March
27, 2007, at 2:05 p.m. Eastern Time in New York, NY. The
presentation will include an overview of the company, current
products, product pipeline and recent financial performance. About
Cholestech Cholestech is committed to enabling people to lead
longer, healthier and more active lives. Cholestech provides easy
to use, accessible diagnostic tools and information to health care
practitioners in over 35 countries around the world. Cholestech
offers efficient and economic diagnostic testing for cholesterol
and related lipids, blood glucose and glycemic control, and liver
enzymes at the point of care. Health care providers can use the
CLIA-waived Cholestech LDX(R) and GDX(TM)* Systems and the hs-CRP
test, which is cleared by the FDA for use in moderate complexity
labs, to initiate and monitor the progress of patient therapy. By
providing effective disease management solutions, Cholestech's goal
is to be a leading provider of diagnostic tools and information for
immediate risk assessment and therapeutic monitoring of heart
disease, inflammatory disorders and diabetes. *The GDX system is
510(k) cleared for prescription home use and, accordingly, is CLIA
waived. Cholestech LDX is a registered trademark and Cholestech GDX
is a trademark of Cholestech Corporation. All other trademarks
mentioned in this document are the property of their respective
owners. For more information about Cholestech and its products
visit us on the web at http://www.cholestech.com/. CTEC-F
DATASOURCE: Cholestech Corporation CONTACT: Jack Glenn, Chief
Financial Officer of Cholestech Corporation, +1-510-781-5065, or ;
or investors, Brendan Lahiff of Financial Dynamics,
+1-415-439-4504, or , for Cholestech Corporation Web site:
http://www.cholestech.com/
Copyright
Global X CleanTech ETF (NASDAQ:CTEC)
Historical Stock Chart
Von Nov 2024 bis Dez 2024
Global X CleanTech ETF (NASDAQ:CTEC)
Historical Stock Chart
Von Dez 2023 bis Dez 2024
Echtzeit-Nachrichten über Global X CleanTech ETF (NASDAQ): 0 Nachrichtenartikel
Weitere Cholestech (MM) News-Artikel